Effectiveness of Subtalar Arthroereisis With Endorthesis for Pediatric Flexible Flat Foot
NCT ID: NCT03372642
Last Updated: 2017-12-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
60 participants
OBSERVATIONAL
2016-03-01
2017-02-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Subtalar endorthesis
Patients who underwent subtalar endorthesis for flexible pediatric flatfoot
Subtalar endorthesis
Subtalar arthroereisis with endorthesis for pediatric flexible flat foot
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Subtalar endorthesis
Subtalar arthroereisis with endorthesis for pediatric flexible flat foot
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age ≥ 14 years at the time of the visit
* patients who underwent subtalar endothesis for the treatment of the pediatric flexible flatfoot from January 2011 to March 2015.
Exclusion Criteria
* patients with comorbidities that make it difficult to return to the hospital for consultation or who have removed the device for discomfort
* female patients who do not exclude (by self-declaration, as clinical practice) a state of pregnancy
14 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EndSP
Identifier Type: -
Identifier Source: org_study_id